
Ligand Pharmaceuticals Inc
LGNDNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$234.79
Day High
$237.15
Day Low
$229.98
Prev. Close
$234.66
VolumeShares traded today.
139.27K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$4.65B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
31.24
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$247.38
52W LowLowest price over the past 52 weeks.
$100.67
50D MAAverage closing price over the last 50 trading days.
$218.21
200D MAAverage closing price over the last 200 trading days.
$195.14
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+4.4%1M
+3.2%6M
+14.0%YTD
+22.0%1Y
+127.0%About
Ligand Pharmaceuticals is an American biopharmaceutical company that focuses on acquiring and developing royalty-generating assets. As of 2024, the company's portfolio included royalty rights to approximately 90 pharmaceutical products across a range of therapeutic areas. Notable products from which Ligand receives royalties include the multiple myeloma (cancer) treatments Kyprolis and Evomela, the kidney disease therapy Filspari, and the pneumococcal vaccine Vaxneuvance. The company also owns the drug development technology platform Captisol.
www.ligand.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade LGND
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.